TRACE4AD

JSON twin: https://www.healthaidb.com/software/trace4ad.json

Company Name

DeepTrace Technologies

Product URL

https://www.deeptracetech.com/en/products/trace4ad

Company URL

https://www.deeptracetech.com/

Categories

• diagnostic Support
• clinical Care
• imaging Software
• predictive Analytics
• Diagnostic
• Clinical
• Neuroimaging

Summary

TRACE4AD is an AI-powered medical device that predicts the risk of Alzheimer's disease dementia within 24 months by analyzing brain MRI scans and cognitive measures.

Description

TRACE4AD is a CE-cleared medical device developed by DeepTrace Technologies, utilizing machine learning to analyze brain MRI images and cognitive assessments to predict the risk of Alzheimer's disease dementia within 24 months. It identifies features of brain atrophy associated with early stages of Alzheimer's and provides volume measurements to aid in disease categorization and tracking progression.

Api Available

unknown

Certifications

• CE Mark
• Class I MDD

Company Founding

2018

Company Offices

• Italy
• United States

Compliance

• HIPAA
• GDPR
• ISO 27001

Customers

Data Residency

EU-only

Data Standards

• DICOM
• Nifti
• nrrd
• PDF

Deployment Model

• SaaS
• on_prem
• hybrid

Features

• AI-powered risk assessment for Alzheimer's disease dementia
• Automatic analysis of brain MRI scans
• Identification of brain atrophy features associated with Alzheimer's
• Volume measurements from T1-weighted MRI studies
• Integration with cognitive measures for comprehensive assessment
• Sensitivity >85%, specificity >80%, PPV >82%, NPV >85%
• CE Mark certified as a medical device

Id

SW0685

Integration Partners

Integrations

• MRI scanners
• Cognitive assessment tools

Languages Supported

• English
• Italian

Last Updated

2025-10-11

License

commercial

Market Segment

• enterprise
• smb

Optional Modules

Os Platforms

• Web

Pricing Details

Contact vendor for pricing information.

Pricing Model

subscription

Privacy Features

• BAA available
• Consent management
• Data anonymization

Product Code

SW0685

Product Name

TRACE4AD

Ratings

Regions Available

• Europe
• North America

Related Urls

• https://healthairegister.com/radiology/products/deeptrace-trace4ad

Release Year

2025

Security Features

• Encryption
• RBAC
• Audit logs

Specialties

• Neurology
• Geriatrics
• Radiology

Support Channels

System Requirements

Dedicated hardware, Cloud-based

Target Users

• neurologists
• radiologists
• clinicians

Training Options

Type

product

User Reviews

Version

1.0

Alternatives

See related products

Canonical JSON

{
  "product_name": "TRACE4AD",
  "company_name": "DeepTrace Technologies",
  "product_url": "https://www.deeptracetech.com/en/products/trace4ad",
  "company_url": "https://www.deeptracetech.com/",
  "related_urls": [
    "https://healthairegister.com/radiology/products/deeptrace-trace4ad"
  ],
  "product_code": "SW0685",
  "summary": "TRACE4AD is an AI-powered medical device that predicts the risk of Alzheimer's disease dementia within 24 months by analyzing brain MRI scans and cognitive measures.",
  "description": "TRACE4AD is a CE-cleared medical device developed by DeepTrace Technologies, utilizing machine learning to analyze brain MRI images and cognitive assessments to predict the risk of Alzheimer's disease dementia within 24 months. It identifies features of brain atrophy associated with early stages of Alzheimer's and provides volume measurements to aid in disease categorization and tracking progression.",
  "categories": [
    "diagnostic Support",
    "clinical Care",
    "imaging Software",
    "predictive Analytics",
    "Diagnostic",
    "Clinical",
    "Neuroimaging",
    "Predictive Analytics"
  ],
  "market_segment": [
    "enterprise",
    "smb"
  ],
  "target_users": [
    "neurologists",
    "radiologists",
    "clinicians"
  ],
  "specialties": [
    "Neurology",
    "Geriatrics",
    "Radiology"
  ],
  "regions_available": [
    "Europe",
    "North America"
  ],
  "languages_supported": [
    "English",
    "Italian"
  ],
  "pricing_model": "subscription",
  "pricing_details": "Contact vendor for pricing information.",
  "license": "commercial",
  "company_offices": [
    "Italy",
    "United States"
  ],
  "company_founding": "2018",
  "deployment_model": [
    "SaaS",
    "on_prem",
    "hybrid"
  ],
  "os_platforms": [
    "Web"
  ],
  "features": [
    "AI-powered risk assessment for Alzheimer's disease dementia",
    "Automatic analysis of brain MRI scans",
    "Identification of brain atrophy features associated with Alzheimer's",
    "Volume measurements from T1-weighted MRI studies",
    "Integration with cognitive measures for comprehensive assessment",
    "Sensitivity >85%, specificity >80%, PPV >82%, NPV >85%",
    "CE Mark certified as a medical device"
  ],
  "optional_modules": [],
  "integrations": [
    "MRI scanners",
    "Cognitive assessment tools"
  ],
  "data_standards": [
    "DICOM",
    "Nifti",
    "nrrd",
    "PDF"
  ],
  "api_available": "unknown",
  "system_requirements": "Dedicated hardware, Cloud-based",
  "compliance": [
    "HIPAA",
    "GDPR",
    "ISO 27001"
  ],
  "certifications": [
    "CE Mark",
    "Class I MDD"
  ],
  "security_features": [
    "Encryption",
    "RBAC",
    "Audit logs"
  ],
  "privacy_features": [
    "BAA available",
    "Consent management",
    "Data anonymization"
  ],
  "data_residency": "EU-only",
  "customers": [],
  "user_reviews": [],
  "ratings": [],
  "support_channels": [],
  "training_options": [],
  "release_year": "2025",
  "integration_partners": [],
  "id": "SW0685",
  "slug": "trace4ad",
  "type": "product",
  "version": "1.0",
  "last_updated": "2025-10-11",
  "links_json": {
    "self": "https://www.healthaidb.com/software/trace4ad.json"
  }
}